Background: Glaucoma is an acquired degeneration of the optic nerve and a leading cause
of blindness worldwide. Medical and surgical treatments that decrease intraocular pressure …

This review examines glaucoma as a disease of early cellular senescence. There is ample
evidence for this position, for both the anterior and the posterior ocular segments. The …

Primary open angle glaucoma (POAG) is a leading cause of blindness worldwide. The
molecular signaling involved in the pathogenesis of POAG remains unknown. Here, we …

Neuroprotection in glaucoma: present and future : Chinese Medical Journal
Neuroprotection in glaucoma: present and future : Chinese Medical Journal Log in or …

Translational research frequently fails to replicate in the clinic what has been demonstrated
in the laboratory. This has been true for neuroprotection in the central nervous system …

Glaucoma is a group of heterogeneous disorders involving progressive optic neuropathy
that can culminate into visual impairment and irreversible blindness. Effective therapeutic …

Intraocular pressure (IOP)-lowering therapy has been shown to arrest or retard the
progression of optic neuropathy typical for glaucoma and can, thus, be described as …

Recent advances have seen a surge of new ideas and technologies to aid in the detection,
treatment and further understanding of glaucoma. These technologies and advances are …

Normal tension glaucoma (NTG) is a common form of open-angle glaucoma that can lead to
significant visual morbidity. There has been considerable debate as to whether NTG fits …

Melatonin is currently considered a promising drug for glaucoma treatment because of its
ocular hypotensive and neuroprotective effects. We have investigated the effect of melatonin …